University of Michigan Health Rogel Cancer Center scientists have found a potential solution for preventing a common and dangerous complication in patients that receive stem cell transplants from a donor’s blood or bone marrow.  

Ryder Washington needs a bone marrow transplant. But the five-year-old, like many other African-Americans, doesn’t have any matches in the national bone marrow registry. His parents are out to change that.

New research suggests gastrointestinal diseases caused by immune system T cells could be mitigated by bolstering a common enzyme.

In a clinical trial, adding interferon treatment with a bone marrow transplant bolstered outcomes for patients with advanced, high-risk leukemia.

Olivia Goff was diagnosed with cancer twice before age 21. But she kept her goals in sight, eventually becoming a nurse on the same floor she received treatment.

How one long noncoding RNA could help improve outcomes in bone marrow and solid organ transplantation.

A new understanding of intracellular pathways activated as T cells start to mount an immune response offers clues against graft-versus-host disease, a serious complication of bone marrow transplantation.

MPS-1 had recently been added to the newborn screening panel when Minette was born, leading to an early diagnosis and the first stem cell transplant at Mott for a lysosomal storage disorder. 

After Shavonn Burgess got her daughter’s diagnosis, she had no idea how her family would cope. Now, after a year of blood transfusions and spleen removal, they’ve found a new normal.

A patient’s genetic makeup and journey with leukemia highlights the need for more gene sequencing in minority children.

When Dan Wagner’s leukemia came back, he was devastated. Now he’s celebrating five years’ cancer-free, thanks to his donor and new life-long friend.

A rare childhood bone marrow disease made social distancing a requirement for one patient to mitigate the risk of infection long before COVID-19 required it of everyone.

While it plays a protective role in other diseases, knocking out NLRP6 in mice led to better outcomes, less-severe symptoms after bone marrow transplant.

Joining the bone marrow registry is the first step to being the cure for patients with blood cancers like leukemia

See the latest research on graft vs host disease (GVHD), including new ways to prevent and treat this potentially fatal side effect of stem cell transplants.